Create an Account
  1. Home
  2. Programs
  3. PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities

PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities

Meeting report with presentation slides, video and online CME of a PACE-CME symposium held during ESC 2020, The Digital Experience.

Episodes 1-4 of 4

  • Introduction PCSKi LDLc Guidelines Practice InnovationIntroduction PCSKi LDLc Guidelines Practice Innovation
    PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
    Introduction: PCSK9i & LDL-c - Guidelines, Practice & Innovation
    • Prof. John Kastelein, MD
      Prof. John Kastelein, MD

      Prof. John Kastelein, MD

  • Time to reduce implementation gaps of lipidlowering therapyTime to reduce implementation gaps of lipidlowering therapy
    PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
    Time to reduce implementation gaps of lipid-lowering therapy
    • Prof Kausik Ray
      Prof Kausik Ray

      Prof Kausik Ray

  • Five years of PCSKi Lessons from practice Which patients benefit mostFive years of PCSKi Lessons from practice Which patients benefit most
    PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
    Five years of PCSK9i - Lessons from practice: Which patients benefit most?
    • Prof. Erik Stroes, MD
      Prof. Erik Stroes, MD

      Prof. Erik Stroes, MD

  • One year after the new ESCEAS dyslipidemia guidelinesOne year after the new ESCEAS dyslipidemia guidelines
    PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
    One year after the new ESC/EAS dyslipidemia guidelines
    • Prof. François Mach, MD
      Prof. François Mach, MD

      Prof. François Mach, MD

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free